NCT05670717 is a clinical trial in Hip Arthropathy, sponsored by Assiut University.

Who is sponsoring NCT05670717?

NCT05670717 is sponsored by Assiut University.

What condition does NCT05670717 study?

NCT05670717 studies Hip Arthropathy.

Is NCT05670717 still recruiting?

NCT05670717 is currently status unknown. Last updated 4 January 2023.

Last reviewed 2023-01-04 · How we verify

NCT05670717

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Subsidence of Cementless Stem Following Arthroplasty for Fracture Neck of Femur

Status unknown Last updated 4 January 2023

What this trial tests

trial in Hip Arthropathy in 50 participants. Status unknown.

Timeline

1 February 2023

Primary endpoint
1 May 2024

1 July 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 February 2023
Primary completion	1 May 2024
Estimated completion	1 July 2024

Conditions studied

Hip Arthropathy — all drugs for Hip Arthropathy →

Sponsor

Assiut University

Who can join

Under 80, any sex, with Hip Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of subsidence of cementless stem following arthroplasty for fracture neck of femur.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hip Arthropathy

Currently open trials in the same condition.

NCT07023094 — PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery · Phase 4 · recruiting
NCT06017128 — Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: a PLISSIT Model Study · NA · active not recruiting
NCT06603831 — Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology · NA · recruiting
NCT06317870 — Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty · NA · recruiting
NCT06432543 — Polyethylene Wear Particle Analysis of THA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05670717 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 4 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05670717.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing